Significantly, the genetic, biochemical, and neuropathological interactions between ATXN2 and TDP-43 strongly suggest the involvement of ATXN2 mutations in the pathogenesis of ALS and related conditions [13]. This evidence concerns the gene ATXN2 and amyotrophic lateral sclerosis.